Only eight people will take part in the first known clinical trial testing the safety of embryonic stem cells in humans and each patient will go through a very stringent selection process, the lead researcher of the study said on Monday. Get the full story »
Inside these posts: stem cell research
Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
April 27, 2010 at 11:16 a.m.
Comments Off
Filed under: Chicago executives, Health care, Investing, Private equity Zell an investor in Cellular Dynamics
From the Milwaukee Journal-Sentinel | Madison-based Cellular Dynamics, the company created by stem cell pioneer James Thompson, confirmed on Tuesday it has raised $40.6 million of private equity funding. The round was led by Tactics II Stem Cell Ventures, with Sam Zell’s Equity Group Investments LLC and Sixth Floor Investors LP participating in the round. This brings the total amount of money raised by the company to $70 million.
Get the full story: jsonline.com.
